At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The VAX-MOM Study: Increasing Influenza and Tdap Vaccination of Pregnant Women
In Brief
A clinical study evaluating VAX-MOM Intervention and Standard of Care for Immunization; Infection and Pregnancy Related. Completed, enrolled 12,760 participants across 1 site.
Detailed Summary
Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.
Study Details
Timeline
Interventions
The multi-component VAX-MOM intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.
Standard vaccine education and processes provided to patients by obstetric practices.